Somnath Roy | Medical Oncology | Research Excellence Award

Dr. Somnath Roy | Medical Oncology | Research Excellence Award

Tata Medical Center, Kolkata | India

Dr. Somnath Roy is a distinguished medical oncologist with a strong academic foundation and extensive clinical experience in leading oncology centers in India. He completed his MBBS from North Bengal Medical College, followed by a PG Diploma and MD in Radiotherapy from WBUHS, and later earned his DM in Medical Oncology from Homi Bhabha National Institute, Mumbai. His professional journey includes serving as Junior and Senior Resident at IPGMER & SSKM Hospital, Kolkata, and subsequently as Senior Resident at Tata Memorial Hospital, Mumbai, where he strengthened his expertise in multidisciplinary cancer care. Dr. Roy’s research background is notable, holding the European Certificate in Medical Oncology (ECMO), MRCP(UK) Specialty Certificate in Medical Oncology, and DNB in Medical Oncology. He has actively led multiple Phase III clinical trials as Principal Investigator in prostate, breast, lung, and ovarian cancers. His scholarly impact includes 94 citations across 90 documents, 27 publications, and an h-index of 6, reflecting meaningful contributions to oncology literature. His key research interests span solid tumors, novel therapeutics, precision oncology, and clinical trial development. Recognized for his commitment to evidence-based practice and academic excellence, Dr. Roy continues to advance high-quality cancer care and research with dedication and integrity.

Profile : Scopus 

Featured Publications

Primary Mediastinal Germ Cell Tumors: A Real-World Analysis of Clinical Characteristics, Treatment, and Survival Outcomes From Two Tertiary Cancer Centers in India
JCO Global Oncology, 2025

Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer
European Journal of Cancer, 2024

Wei Dai | Quantitative Research | Research Excellence Award

Dr. Wei Dai | Quantitative Research | Research Excellence Award

Sichuan Cancer Hospital | China

Dr. Wei Dai is an accomplished thoracic surgeon and researcher specializing in minimally invasive surgery for lung cancer and the integration of patient-reported outcomes (PROs) into perioperative care. He earned his MD in Clinical Medicine from Southern Medical University, an MSc in Thoracic Surgery from Peking Union Medical College, a PhD in Thoracic Surgery from Sichuan University, and completed a fellowship in Thoracic Surgery at the University Hospital of Copenhagen, Rigshospitalet. Dr. Dai has progressed through roles from thoracic surgery trainee and resident to attending surgeon, and currently serves as an associate consultant at Sichuan Cancer Hospital. His research focuses on the development and implementation of PRO-based databases, optimization of postoperative symptom management, and enhancement of patient rehabilitation and recovery pathways. Dr. Dai has led multiple national and provincial research grants, including multicenter randomized controlled trials, and has been instrumental in establishing REDCap-based medical research platforms. He has authored over 60 peer-reviewed publications in high-impact journals and serves as a reviewer for several international journals. An active member of leading professional societies, including ESTS, IASLC, and ISOQOL, Dr. Dai is dedicated to advancing precision perioperative care and improving the quality of life for lung cancer patients. His work bridges clinical innovation, research excellence, and patient-centered care.

Profile : Orcid

Featured Publications

Liu, J., Ma, H., Li, D., Li, Y., Qing, H., Wei, X., Shi, Q., Li, Q., Dai, W., & Zhou, P. (2025). “ASO visual abstract: Early post-discharge pain trajectories after thoracoscopic sublobar resection for Stage IA non-small cell lung cancer.” Annals of Surgical Oncology.

Liu, J., Ma, H., Li, D., Li, Y., Qing, H., Wei, X., Shi, Q., Li, Q., Dai, W., & Zhou, P. (2025). “Early post-discharge pain trajectories after thoracoscopic sublobar resection for Stage IA non-small cell lung cancer.” Annals of Surgical Oncology.

Tian, X., Mao, P., Lei, C., Yu, H., Dai, W., Wei, X., Zhang, J., Xu, W., & Shi, Q. (2025). “Patient-reported walking difficulty predicting the post-discharge overall function in patients with lung cancer undergoing minimally invasive surgery.” Journal of Cancer Survivorship.

Liao, J., Hu, X., Wei, X., Dai, W., Yu, H., Tian, X., Wang, Y., Qin, Q., Xu, N., Li, Y., et al. (2025). “Sex-related differences in postoperative patient-reported outcomes among lung cancer patients: A multicenter cohort study.” BMC Cancer.

Zheng, H., Guo, C., Zhang, Y., Gu, H., Zhao, Y., Xiang, R., Dai, W., Wei, X., Xie, T., Li, Q., et al. (2025). “Single staged repair of an anastomotic tracheal fistula following Mckeown esophagectomy via cervical incision: A case report.” Journal of Cardiothoracic Surgery.